{
    "body": "Mutation of which gene is implicated in the familial isolated pituitary adenoma?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23743763", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24078436", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24050928", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20457215", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22915287", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17961654", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23633209", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17244780", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21450940", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23286415", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23652674", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21778740", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17893250", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22527616", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21454441", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20570174", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24423289", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20616498", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22584704", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24996936", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20669561", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20616502", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19883897", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24366639", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23371967", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20506337", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20833337", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23310926", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24789813", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22291433", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23038625", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17993773", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21498161"
    ], 
    "ideal_answer": [
        "Mutation of aryl hydrocarbon receptor interacting protein (AIP) gene was implicated in the familial isolated pituitary adenoma (FIPA) syndrome. About 20% of the families with FIPA harbor inactivating mutation in AIP gene."
    ], 
    "exact_answer": [
        "aryl hydrocarbon receptor interacting protein"
    ], 
    "type": "factoid", 
    "id": "551c23bc6b348bb82c00000b", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 162, 
            "text": "The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24078436", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 107, 
            "text": "Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24078436", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 883, 
            "offsetInEndSection": 1014, 
            "text": "We report a Spanish family with FIPA in whom a mutation in the AIP gene previously unreported in a familiar context was identified.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24078436", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 785, 
            "offsetInEndSection": 1068, 
            "text": "FIPA, an autosomal-dominant disease with variable penetrance, is explained in 20% of patients by germline mutations in the tumor suppressor aryl hydrocarbon receptor interacting protein(AIP), while no gene abnormality has been identified to date in the majority of the FIPA families.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23652674", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1308, 
            "offsetInEndSection": 1486, 
            "text": "Understanding the tumorigenic process in AIP-positive and AIP-negative FIPA patients could result in better diagnostic and treatment options for both familial and sporadic cases.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23652674", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 93, 
            "offsetInEndSection": 230, 
            "text": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23633209", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 275, 
            "offsetInEndSection": 581, 
            "text": " The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23310926", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 860, 
            "offsetInEndSection": 977, 
            "text": " This review aims to summarize currently available clinical data on AIP mutation-positive and negative FIPA patients.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23310926", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 94, 
            "text": "[Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23286415", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 337, 
            "offsetInEndSection": 424, 
            "text": "Many heterozygous mutations have been discovered in AIP in about 20% of FIPA families. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23286415", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 306, 
            "text": "Germline mutations of aryl-hydrocarbon-receptor interacting protein (AIP) are associated with pituitary adenoma predisposition. They occur in 20\u00a0% of familial isolated pituitary adenoma (FIPA) and in about 3-5\u00a0% of sporadic pituitary adenomas, especially in early onset somatotropinomas and prolactinomas. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22915287", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1046, 
            "offsetInEndSection": 1188, 
            "text": "We report a FIPA family harbouring an AIP R16H change, supporting the hypothesis that the latter represents a variant of unknown significance.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22915287", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 659, 
            "offsetInEndSection": 805, 
            "text": "Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22584704", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 214, 
            "text": "Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527616", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 305, 
            "offsetInEndSection": 633, 
            "text": "About 20 % of the families with FIPA harbor inactivating mutation in aryl hydrocarbon receptor-interacting protein gene (AIP) associated with loss of heterozygosity of the same genetic locus (11q13) in the tumor. Rarely different types of extra-pituitary tumors have been described in the setting of AIP mutation-positive FIPA. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527616", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 138, 
            "offsetInEndSection": 197, 
            "text": "Mutations in AIP account only for 15-25% of FIPA families. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22291433", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 340, 
            "offsetInEndSection": 559, 
            "text": "In 20-40% of families with this syndrome, mutations have been identified in the aryl hydrocarbon receptor interacting protein gene while in the rest of the families the causative gene or genes have not been identified. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21498161", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 261, 
            "text": "Germline mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP) predispose to young-onset pituitary tumours, most often to GH- or prolactin-secreting adenomas, and most of these patients belong to familial isolated pituitary adenoma families.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21454441", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1299, 
            "offsetInEndSection": 1628, 
            "text": "We also briefly describe the genetic basis of three other inherited states predisposing individuals to endocrine tumors, namely Carney's syndrome, hyperparathyroidism type 2 (HRPT2) and familial isolated pituitary adenoma (FIPA), which are related to inactivating mutations in the PRKAR1-alpha, HRPT2 and AIP genes, respectively.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20669561", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 264, 
            "text": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616498", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 425, 
            "offsetInEndSection": 655, 
            "text": "Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616498", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 353, 
            "offsetInEndSection": 538, 
            "text": "In 20% of FIPA families, heterozygous mutations have been described in the aryl hydrocarbon receptor interacting (AIP) gene, whereas in other families the causative gene(s) are unknown.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20570174", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 160, 
            "text": "A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789813", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 166, 
            "text": "Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23371967", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 659, 
            "offsetInEndSection": 804, 
            "text": "Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22584704", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Mutations of the aryl hydrocarbon receptor interacting protein (AIP) gene are associated with pituitary adenomas that usually occur as familial isolated pituitary adenomas (FIPA).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21450940", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 183, 
            "text": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24423289", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 130, 
            "text": "Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22291433", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 237, 
            "text": "Although the cause of familial isolated pituitary adenoma (FIPA) remains unknown in many cases, germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene were identified in approximately 20 % of families with FIPA", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24789813", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 159, 
            "text": "The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24078436", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 784, 
            "offsetInEndSection": 1066, 
            "text": "FIPA, an autosomal-dominant disease with variable penetrance, is explained in 20% of patients by germline mutations in the tumor suppressor aryl hydrocarbon receptor interacting protein(AIP), while no gene abnormality has been identified to date in the majority of the FIPA families", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23652674", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 659, 
            "offsetInEndSection": 803, 
            "text": "Germline mutations in the aryl-hydrocarbon interacting protein gene are identified in around 25% of familial isolated pituitary adenoma kindreds", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22584704", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 263, 
            "text": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20616498", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 622, 
            "offsetInEndSection": 1111, 
            "text": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21778740", 
            "endSection": "abstract"
        }
    ]
}